BB Biotech AG (BION) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.049x

Based on the latest financial reports, BB Biotech AG (BION) has a cash flow conversion efficiency ratio of -0.049x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-150.88 Million ≈ $-190.75 Million USD) by net assets (CHF3.08 Billion ≈ $3.90 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BION market cap overview for the company's overall valuation and market capitalisation.

BB Biotech AG - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how BB Biotech AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BB Biotech AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BB Biotech AG ranked by their cash flow conversion efficiency. Explore BB Biotech AG (BION) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Ningbo Sanxing Medical Electric Co Ltd SHG:601567	0.043x
SKC Co. Ltd KO:011790	-0.121x
LG Household & Healthcare KO:051900	0.016x
Brookfield Business Partners L.P. TO:BBU-UN	0.049x
Digitalbridge Group Inc NYSE:DBRG	0.018x
OLAM GROUP LTD F:K25	N/A
Baoding Tianwei Baobian Electric Co Ltd SHG:600550	0.172x
Tikehau Capital PA:TKO	0.031x

Annual Cash Flow Conversion Efficiency for BB Biotech AG (2003–2025)

The table below shows the annual cash flow conversion efficiency of BB Biotech AG from 2003 to 2025. View BION live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF2.78 Billion ≈ $3.51 Billion	CHF309.14 Million ≈ $390.84 Million	0.111x	-16.48%
2024-12-31	CHF2.29 Billion ≈ $2.89 Billion	CHF304.56 Million ≈ $385.05 Million	0.133x	+41.78%
2023-12-31	CHF2.32 Billion ≈ $2.94 Billion	CHF218.28 Million ≈ $275.96 Million	0.094x	+170.53%
2022-12-31	CHF2.69 Billion ≈ $3.40 Billion	CHF-357.81 Million ≈ $-452.37 Million	-0.133x	-8.23%
2021-12-31	CHF3.29 Billion ≈ $4.16 Billion	CHF-404.81 Million ≈ $-511.79 Million	-0.123x	-282.90%
2020-12-31	CHF3.90 Billion ≈ $4.93 Billion	CHF262.45 Million ≈ $331.81 Million	0.067x	+6.19%
2019-12-31	CHF3.39 Billion ≈ $4.29 Billion	CHF215.02 Million ≈ $271.84 Million	0.063x	+138.78%
2018-12-31	CHF2.88 Billion ≈ $3.65 Billion	CHF-471.34 Million ≈ $-595.90 Million	-0.163x	-184.11%
2017-12-31	CHF3.54 Billion ≈ $4.47 Billion	CHF687.50 Million ≈ $869.19 Million	0.194x	+172.74%
2016-12-31	CHF3.00 Billion ≈ $3.80 Billion	CHF-802.07 Million ≈ $-1.01 Billion	-0.267x	-262.76%
2015-12-31	CHF3.98 Billion ≈ $5.03 Billion	CHF652.82 Million ≈ $825.34 Million	0.164x	-61.02%
2014-12-31	CHF3.49 Billion ≈ $4.42 Billion	CHF1.47 Billion ≈ $1.86 Billion	0.421x	-4.28%
2013-12-31	CHF2.12 Billion ≈ $2.68 Billion	CHF931.83 Million ≈ $1.18 Billion	0.440x	+47.54%
2012-12-31	CHF1.23 Billion ≈ $1.56 Billion	CHF367.83 Million ≈ $465.04 Million	0.298x	+76.14%
2011-12-31	CHF1.00 Billion ≈ $1.27 Billion	CHF169.52 Million ≈ $214.32 Million	0.169x	+992.62%
2010-12-31	CHF1.23 Billion ≈ $1.56 Billion	CHF-23.41 Million ≈ $-29.60 Million	-0.019x	-117.13%
2009-12-31	CHF1.52 Billion ≈ $1.92 Billion	CHF167.84 Million ≈ $212.19 Million	0.111x	-67.30%
2008-12-31	CHF1.50 Billion ≈ $1.90 Billion	CHF509.39 Million ≈ $644.01 Million	0.339x	+197.58%
2007-12-31	CHF1.77 Billion ≈ $2.23 Billion	CHF201.02 Million ≈ $254.14 Million	0.114x	+1394.02%
2006-12-31	CHF2.25 Billion ≈ $2.85 Billion	CHF-19.80 Million ≈ $-25.04 Million	-0.009x	-226.35%
2005-12-31	CHF2.28 Billion ≈ $2.88 Billion	CHF-6.14 Million ≈ $-7.76 Million	-0.003x	-104.81%
2004-12-31	CHF1.91 Billion ≈ $2.42 Billion	CHF107.32 Million ≈ $135.68 Million	0.056x	+163.12%
2003-12-31	CHF1.94 Billion ≈ $2.45 Billion	CHF-172.22 Million ≈ $-217.73 Million	-0.089x	--

About BB Biotech AG

SW:BION Switzerland Biotechnology

Market Cap

$3.65 Billion

CHF2.88 Billion CHF

Market Cap Rank

#5018 Global

#75 in Switzerland

Share Price

CHF52.30

Change (1 day)

+0.19%

52-Week Range

CHF35.40 - CHF56.80

All Time High

CHF78.42